• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    CytRx Corporation (CYTR)

    -NasdaqCM
    2.50 Up 0.37(17.37%) Feb 12, 4:00PM EST
    Prev Close:2.13
    Open:2.15
    Bid:1.96 x 1000
    Ask:2.67 x 100
    1y Target Est:7.40
    Beta:2.94996
    Earnings Date:Mar 8 - Mar 14 (Est.)
    Day's Range:2.15 - 2.57
    52wk Range:1.55 - 5.42
    Volume:1,271,065
    Avg Vol (3m):467,595
    Market Cap:166.20M
    P/E (ttm):N/A
    EPS (ttm):-0.86
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CYTRUp 17.37%166.20M
    LLYDown 0.21%75.47B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,416.02
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.81
    Quarterly EPS Est (Dec-15) :-0.20
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate is aldoxorubicin, which is in Phase III clinical trial as a therapy for patients with soft tissue sar... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback